Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PASS: Cilostazol vs Aspirin in Acute Ischemic Stroke
NCT03116269Phase 4Completed
- Sponsor
- Ajou University School of Medicine
- Start
- Mar 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of cilostazol in ischemic stroke and Transient Ischemic Attack (TIA) (2 arms), sponsored by Ajou University School of Medicine. Primary endpoint: Flow Mediated Dilation at 3 months. Started Mar 2012; status: completed.
02
Drugs
cilostazol
03
Conditions
ischemic strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT03116269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03116269.